{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T19:43:09Z","timestamp":1793475789881,"version":"4.5.0"},"reference-count":213,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1053\/j.gastro.2023.01.033","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T11:57:47Z","timestamp":1675339067000},"page":"766-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":596,"title":["Global Epidemiology and Genetics of Hepatocellular Carcinoma"],"prefix":"10.1053","volume":"164","author":[{"given":"Ming Ren","family":"Toh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Yi Ting","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny Hei","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin Wei Tian","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lit-Hsin","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierce Kah-Hoe","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ngeow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2023.01.033_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2023.01.033_bib2","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3748\/wjg.v28.i3.310","article-title":"Non-alcoholic fatty liver disease and hepatocellular carcinoma: clinical challenges of an intriguing link","volume":"28","author":"Chrysavgis","year":"2022","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib3","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Vos","year":"2020","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.01.033_bib4","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/hep4.1564","article-title":"hepatocellular carcinoma survival by etiology: a SEER-Medicare database analysis","volume":"4","author":"Brar","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib5","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jhep.2016.10.015","article-title":"Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country","volume":"66","author":"Goutt\u00e9","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib6","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cam4.4530","article-title":"The burden of primary liver cancer caused by specific etiologies from 1990 to 2019 at the global, regional, and national levels","volume":"11","author":"Yang","year":"2022","journal-title":"Cancer Med"},{"key":"10.1053\/j.gastro.2023.01.033_bib7","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","article-title":"The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015","volume":"3","author":"Akinyemiju","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib8","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","article-title":"A\u00a0global view of hepatocellular carcinoma: trends, risk, prevention and management","volume":"16","author":"Yang","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view","volume":"7","author":"Yang","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib10","series-title":"National Cancer Institute","year":"2020"},{"key":"10.1053\/j.gastro.2023.01.033_bib11","first-page":"44","article-title":"Interactions between life expectancy and the incidence and mortality rates of cancer in China: a population-based cluster analysis","volume":"38","author":"Gu","year":"2018","journal-title":"Cancer Commun (Lond)"},{"key":"10.1053\/j.gastro.2023.01.033_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.cld.2019.04.001","article-title":"Global perspective on hepatitis B virus infections in the era of effective vaccines","volume":"23","author":"Gomes","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2023.01.033_bib13","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1038\/nrgastro.2013.107","article-title":"Epidemiology and natural history of HCV infection","volume":"10","author":"Hajarizadeh","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/hep.31288","article-title":"Epidemiology of hepatocellular carcinoma","volume":"73","author":"McGlynn","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib15","author":"Hepatitis"},{"key":"10.1053\/j.gastro.2023.01.033_bib16","author":"Hepatitis"},{"key":"10.1053\/j.gastro.2023.01.033_bib19","doi-asserted-by":"crossref","first-page":"4182","DOI":"10.3748\/wjg.v27.i26.4182","article-title":"Prevention of vertical transmission of hepatitis B virus infection","volume":"27","author":"Veronese","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.3390\/vaccines10050793","article-title":"The global impact of hepatitis B vaccination on hepatocellular carcinoma","volume":"10","author":"Flores","year":"2022","journal-title":"Vaccines"},{"key":"10.1053\/j.gastro.2023.01.033_bib21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.2013.276701","article-title":"Thirty-year outcomes of the national hepatitis B immunization program in Taiwan","volume":"310","author":"Chiang","year":"2013","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2023.01.033_bib22","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","article-title":"Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma","volume":"28","author":"Sung","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.01.033_bib23","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1053\/j.gastro.2014.03.048","article-title":"Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B\u2014a nationwide cohort study","volume":"147","author":"Wu","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib24","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/hep.26180","article-title":"Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection","volume":"58","author":"Hosaka","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib25","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/hep.26301","article-title":"Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis","volume":"58","author":"Wong","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/liv.13668","article-title":"Is global elimination of HCV realistic?","volume":"38","author":"Calvaruso","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib27","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinre.2020.101596","article-title":"Epidemiology of hepatitis C virus infection","volume":"45","author":"Roudot-Thoraval","year":"2021","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib29","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.jhep.2017.06.033","article-title":"Micro-elimination\u2013a path to global elimination of hepatitis C","volume":"67","author":"Lazarus","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib31","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib32","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5114\/ceh.2020.102153","article-title":"Epidemiology of non-alcoholic fatty liver disease and risk of hepatocellular carcinoma progression","volume":"6","author":"Thandra","year":"2020","journal-title":"Clin Exp Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib34","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","article-title":"Nonalcoholic steatohepatitis: summary of an AASLD single topic conference","volume":"37","author":"Neuschwander-Tetri","year":"2003","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib35","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1470-2045(22)00078-X","article-title":"Clinical characteristics, surveillance, treatment allocation, and outcomes of non-alcoholic fatty liver disease-related hepatocellular carcinoma: a systematic review and meta-analysis","volume":"23","author":"Tan","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/jhep.2002.33713","article-title":"Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis?","volume":"36","author":"Nair","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/hep.30858","article-title":"Diabetes is associated with increased risk of hepatocellular carcinoma in patients with cirrhosis from nonalcoholic fatty liver disease","volume":"71","author":"Yang","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib38","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41575-020-0315-7","article-title":"NAFLD\u2014sounding the alarm on a silent epidemic","volume":"17","author":"Lazarus","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib39","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/hep.23276","article-title":"Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis","volume":"51","author":"Promrat","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/hep4.1618","article-title":"Nonalcoholic fatty liver disease screening in type 2 diabetes mellitus patients in the primary care setting","volume":"5","author":"Vieira Barbosa","year":"2021","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib42","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/annonc\/mdu020","article-title":"Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies","volume":"25","author":"Turati","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/bjc.2014.579","article-title":"Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis","volume":"112","author":"Bagnardi","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib44","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0140-6736(22)00847-9","article-title":"Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020","volume":"400","author":"Bryazka","year":"2022","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.01.033_bib46","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1053\/jhep.2002.36780","article-title":"Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus","volume":"36","author":"Hassan","year":"2002","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib47","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1053\/j.gastro.2004.09.020","article-title":"Alcohol and hepatocellular carcinoma","volume":"127","author":"Morgan","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib49","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1053\/jhep.2001.28233","article-title":"The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis","volume":"34","author":"Kuper","year":"2001","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib50","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jhep.2018.10.008","article-title":"Hepatocellular carcinoma in the setting of alcohol-related liver disease","volume":"70","author":"Ganne-Carri\u00e9","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib51","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1002\/cncr.31215","article-title":"Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: results of a prospective, nationwide study","volume":"124","author":"Costentin","year":"2018","journal-title":"Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.cgh.2022.03.010","article-title":"Clinical characteristics and outcomes of nonalcoholic fatty liver disease\u2013associated hepatocellular carcinoma in the United States","volume":"21","author":"Karim","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib53","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1289\/ehp.0901388","article-title":"Global burden of aflatoxin-induced hepatocellular carcinoma: a risk assessment","volume":"118","author":"Liu","year":"2010","journal-title":"Environ Health Perspect"},{"key":"10.1053\/j.gastro.2023.01.033_bib54","first-page":"466","article-title":"Interaction of hepatitis B virus X protein with the pregnane X receptor enhances the synergistic effects of aflatoxin B1 and hepatitis B virus on promoting hepatocarcinogenesis","volume":"9","author":"Niu","year":"2021","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hsr2.155","article-title":"Analysis of TP53 aflatoxin signature mutation in hepatocellular carcinomas from Guatemala: a cross-sectional study (2016\u20132017)","volume":"3","author":"Alvarez","year":"2020","journal-title":"Health Sci Rep"},{"key":"10.1053\/j.gastro.2023.01.033_bib56","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1053\/j.gastro.2015.05.061","article-title":"Genetic landscape and biomarkers of hepatocellular carcinoma","volume":"149","author":"Zucman-Rossi","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib57","series-title":"Aflatoxins in Food:","first-page":"141","article-title":"Regulations for aflatoxins in developing and industrialized economies","author":"Tahir","year":"2021"},{"key":"10.1053\/j.gastro.2023.01.033_bib58","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3390\/toxins14070442","article-title":"Mycotoxin regulatory status in Africa: a decade of weak institutional efforts","volume":"14","author":"Chilaka","year":"2022","journal-title":"Toxins"},{"key":"10.1053\/j.gastro.2023.01.033_bib59","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1055\/s-0039-1685516","article-title":"Mutational processes in hepatocellular carcinoma: the story of aristolochic acid","volume":"39","author":"Nault","year":"2019","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2023.01.033_bib60","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/scitranslmed.aan6446","article-title":"Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia","volume":"9","author":"Ng","year":"2017","journal-title":"Sci Transl Med"},{"key":"10.1053\/j.gastro.2023.01.033_bib61","doi-asserted-by":"crossref","first-page":"648","DOI":"10.3389\/fphar.2019.00648","article-title":"Systematic overview of aristolochic acids: nephrotoxicity, carcinogenicity, and underlying mechanisms","volume":"10","author":"Han","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1053\/j.gastro.2023.01.033_bib62","first-page":"8","article-title":"Association between hereditary hemochromatosis and hepatocellular carcinoma: a comprehensive review","volume":"6","author":"Jayachandran","year":"2020","journal-title":"Hepatoma Res"},{"key":"10.1053\/j.gastro.2023.01.033_bib63","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.3390\/ijms22084097","article-title":"Iron at the interface of hepatocellular carcinoma","volume":"22","author":"Paganoni","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.gastro.2023.01.033_bib64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1600-0609.1998.tb00993.x","article-title":"African iron overload and hepatocellular carcinoma","volume":"60","author":"Moyo","year":"1998","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.gastro.2023.01.033_bib65","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1002\/hep.510270614","article-title":"Dietary iron overload as a risk factor for hepatocellular carcinoma in black Africans","volume":"27","author":"Mandishona","year":"1998","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib66","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bcmd.2007.03.008","article-title":"SLC40A1 Q248H allele frequencies and Q248H-associated risk of non-HFE iron overload in persons of sub-Saharan African descent","volume":"39","author":"Barton","year":"2007","journal-title":"Blood Cells Mol Dis"},{"key":"10.1053\/j.gastro.2023.01.033_bib67","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1136\/gut.37.5.727","article-title":"Hepatocellular carcinoma and African iron overload","volume":"37","author":"Gangaidzo","year":"1995","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.01.033_bib68","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s40615-018-0483-0","article-title":"Let\u2019s talk about B: barriers to hepatitis B screening and vaccination among Asian and South Asian immigrants in British Columbia","volume":"5","author":"Zibrik","year":"2018","journal-title":"J\u00a0Racial Ethn Health Disparities"},{"key":"10.1053\/j.gastro.2023.01.033_bib69","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1002\/ijc.33313","article-title":"Is it possible to halve the incidence of liver cancer in China by 2050?","volume":"148","author":"Shi","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib70","doi-asserted-by":"crossref","first-page":"571","DOI":"10.21147\/j.issn.1000-9604.2018.06.01","article-title":"Liver cancer incidence and mortality in China: temporal trends and projections to 2030","volume":"30","author":"Zheng","year":"2018","journal-title":"Chin J Cancer Res"},{"key":"10.1053\/j.gastro.2023.01.033_bib71","doi-asserted-by":"crossref","first-page":"270","DOI":"10.35772\/ghm.2021.01080","article-title":"Prevalence, diagnosis, and treatment of hepatitis C in Mainland China","volume":"3","author":"Mei","year":"2021","journal-title":"Global Health Med"},{"key":"10.1053\/j.gastro.2023.01.033_bib72","first-page":"1427","article-title":"Eliminate hepatitis C as a public health threat: a narrative review of strategies, gaps, and opportunities for China","volume":"11","author":"Song","year":"2022","journal-title":"Infect Dis Ther"},{"key":"10.1053\/j.gastro.2023.01.033_bib73","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1001\/jama.1996.03540180012005","article-title":"Armed with epidemiologic research, China launches programs to prevent liver cancer","volume":"276","author":"Skolnick","year":"1996","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2023.01.033_bib74","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/liv.14222","article-title":"Innovative strategies for the elimination of viral hepatitis at a national level: a country case series","volume":"39","author":"Schr\u00f6eder","year":"2019","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib75","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s40249-022-01032-5","article-title":"Impact of the national hepatitis B immunization program in China: a modeling study","volume":"11","author":"Liu","year":"2022","journal-title":"Infect Dis Poverty"},{"key":"10.1053\/j.gastro.2023.01.033_bib76","first-page":"230","article-title":"Countdown to 2030: eliminating hepatitis B disease, China","volume":"97","author":"Liu","year":"2019","journal-title":"Bull WHO"},{"key":"10.1053\/j.gastro.2023.01.033_bib77","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/14787210.2019.1675509","article-title":"How would China achieve WHO\u2019s target of eliminating HCV by 2030?","volume":"17","author":"Li","year":"2019","journal-title":"Expert Rev Anti Infective Ther"},{"key":"10.1053\/j.gastro.2023.01.033_bib78","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1055\/s-0038-1666841","article-title":"The micro-elimination approach to eliminating hepatitis C: strategic and operational considerations","volume":"38","author":"Lazarus","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1053\/j.gastro.2023.01.033_bib79","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2023.01.033_bib80","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/liv.15312","article-title":"Epidemic characteristics of alcohol-related liver disease in Asia from 2000 to 2020: a systematic review and meta-analysis","volume":"42","author":"Xu","year":"2022","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib81","doi-asserted-by":"crossref","first-page":"6163","DOI":"10.1097\/MD.0000000000006163","article-title":"Disease spectrum of alcoholic liver disease in Beijing 302 hospital from 2002 to 2013: a large tertiary referral hospital experience from 7422 patients","volume":"96","author":"Huang","year":"2017","journal-title":"Medicine"},{"key":"10.1053\/j.gastro.2023.01.033_bib82","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib83","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1186\/s12889-022-13175-z","article-title":"A\u00a0cross-sectional study of alcohol consumption and alcoholic liver disease in Beijing: based on 74,998 community residents","volume":"22","author":"Wang","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1053\/j.gastro.2023.01.033_bib84","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S2468-1253(18)30243-7","article-title":"The public health challenge of liver cancer in Mongolia","volume":"3","author":"Znaor","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.5005\/jp-journals-10018-1260","article-title":"Epidemiology, genotype distribution, prognosis, control, and management of viral hepatitis B, C, D, and hepatocellular carcinoma in Mongolia","volume":"8","author":"Baatarkhuu","year":"2018","journal-title":"Euroasian J Hepatogastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib86","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/CEJ.0b013e32833f0c8e","article-title":"Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia","volume":"20","author":"Dondog","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"10.1053\/j.gastro.2023.01.033_bib87","author":"Unurzul"},{"key":"10.1053\/j.gastro.2023.01.033_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12889-021-12070-3","article-title":"Mongolia health situation: based on the Global Burden of Disease Study 2019","volume":"22","author":"Chimed-Ochir","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1053\/j.gastro.2023.01.033_bib89","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00535-018-1532-5","article-title":"A\u00a0nationwide survey on non-B, non-C hepatocellular carcinoma in Japan: 2011-2015 update","volume":"54","author":"Tateishi","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib90","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-022-05444-z","article-title":"Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019","volume":"12","author":"Nakano","year":"2022","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2023.01.033_bib91","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s12876-022-02518-0","article-title":"Global, regional, and national burden of cirrhosis and other chronic liver diseases due to alcohol use, 1990\u20132019: a systematic analysis for the Global Burden of Disease study 2019","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib92","first-page":"808","article-title":"Epidemiology of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Japan: a focused literature review","volume":"4","author":"Eguchi","year":"2020","journal-title":"J\u00a0Gastroenterol Hepatol Open"},{"key":"10.1053\/j.gastro.2023.01.033_bib93","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12072-021-10143-4","article-title":"The epidemiology of NAFLD and lean NAFLD in Japan: a meta-analysis with individual and forecasting analysis, 1995\u20132040","volume":"15","author":"Ito","year":"2021","journal-title":"Hepatol Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib94","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/alcalc\/agw002","article-title":"Prevalence and trends in alcohol dependence and alcohol use disorders in Japanese adults: results from periodical nationwide surveys","volume":"51","author":"Osaki","year":"2016","journal-title":"Alcohol Alcohol"},{"key":"10.1053\/j.gastro.2023.01.033_bib96","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2468-1253(21)00472-6","article-title":"Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study","volume":"7","author":"Blach","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib97","article-title":"Burden of chronic hepatitis B and C infections in 2015 and future trends in Japan: a simulation study","volume":"22","author":"Tanaka","year":"2022","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1053\/j.gastro.2023.01.033_bib98","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1159\/000252782","article-title":"Changing trends in hepatitis C infection over the past 50 years in Japan","volume":"53","author":"Chung","year":"2010","journal-title":"Intervirology"},{"key":"10.1053\/j.gastro.2023.01.033_bib99","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jhep.2004.09.023","article-title":"Molecular evolutionary analyses implicate injection treatment for schistosomiasis in the initial hepatitis C epidemics in Japan","volume":"42","author":"Tanaka","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib100","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1053\/j.gastro.2023.01.033_bib101","doi-asserted-by":"crossref","first-page":"ofz185","DOI":"10.1093\/ofid\/ofz185","article-title":"Trends and efficacy of interferon-free anti\u2013hepatitis C virus therapy in the region of high prevalence of elderly patients, cirrhosis, and hepatocellular carcinoma: a real-world, nationwide, multicenter study of 10,688 patients in Japan","volume":"6","author":"Toyoda","year":"2019","journal-title":"Open Forum Infectious Diseases"},{"key":"10.1053\/j.gastro.2023.01.033_bib103","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5694\/mja2.50885","article-title":"Australian recommendations for the management of hepatocellular carcinoma: a consensus statement","volume":"214","author":"Lubel","year":"2021","journal-title":"Med J Aust"},{"key":"10.1053\/j.gastro.2023.01.033_bib104","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/1753-6405.12889","article-title":"Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide","volume":"43","author":"Cocker","year":"2019","journal-title":"Aust N Z J Public Health"},{"key":"10.1053\/j.gastro.2023.01.033_bib105","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/liv.13966","article-title":"Hepatocellular carcinoma in Australia 1982-2014: increasing incidence and improving survival","volume":"39","author":"Wallace","year":"2019","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib106","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/jvh.13013","article-title":"Australia on track to achieve WHO HCV elimination targets following rapid initial DAA treatment uptake: a modelling study","volume":"26","author":"Kwon","year":"2019","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2023.01.033_bib108","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1440-1746.2006.04459.x","article-title":"Hepatocellular carcinoma in an Australian tertiary referral hospital 1975-2002: change in epidemiology and clinical presentation","volume":"22","author":"Roberts","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S1665-2681(19)31354-7","article-title":"Epidemiology of hepatocellular carcinoma in sub-Saharan Africa","volume":"12","author":"Kew","year":"2015","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib110","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S2468-1253(16)30161-3","article-title":"Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium","volume":"2","author":"Yang","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib111","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4254\/wjh.v2.i2.65","article-title":"Hepatocellular carcinoma in African Blacks: recent progress in etiology and pathogenesis","volume":"2","author":"Kew","year":"2010","journal-title":"World J Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib112","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/jvh.13217","article-title":"Prevalence and burden of HBV co-infection among people living with HIV: a global systematic review and meta-analysis","volume":"27","author":"Platt","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1053\/j.gastro.2023.01.033_bib113","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jhep.2017.07.011","article-title":"How viral genetic variants and genotypes influence disease and treatment outcome of chronic hepatitis B. Time for an individualised approach?","volume":"67","author":"Rajoriya","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib114","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1186\/s12885-018-4695-9","article-title":"Liver cancer mortality trends in South Africa: 1999\u20132015","volume":"18","author":"Mak","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib115","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib116","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S2468-1253(17)30295-9","article-title":"Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets","volume":"2","author":"Spearman","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib117","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12985-020-01443-6","article-title":"Sero-prevalence of human immunodeficiency virus-hepatitis B virus (HIV-HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis","volume":"17","author":"Kafeero","year":"2020","journal-title":"Virol J"},{"key":"10.1053\/j.gastro.2023.01.033_bib118","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(10)61931-9","article-title":"Hepatitis delta virus","volume":"378","author":"Hughes","year":"2011","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.01.033_bib119","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/apt.13795","article-title":"Systematic review with meta-analysis: the risk of mother-to-child transmission of hepatitis B virus infection in sub-Saharan Africa","volume":"44","author":"Keane","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2023.01.033_bib120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/v14010082","article-title":"Global disparities in hepatitis B elimination\u2014a focus on Africa","volume":"14","author":"Sonderup","year":"2022","journal-title":"Viruses"},{"key":"10.1053\/j.gastro.2023.01.033_bib121","doi-asserted-by":"crossref","DOI":"10.9745\/GHSP-D-21-00277","article-title":"Implementation approaches for introducing and overcoming barriers to hepatitis B birth-dose vaccine in sub-Saharan Africa","volume":"10","author":"Boisson","year":"2022","journal-title":"Glob Health Sci Pract"},{"key":"10.1053\/j.gastro.2023.01.033_bib122","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1200\/GO.20.00425","article-title":"Hepatocellular carcinoma in sub-Saharan Africa","volume":"7","author":"Mukthinuthalapati","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib123","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/d41586-022-00819-8","article-title":"Africa's struggle with hepatitis B","volume":"603","author":"Nordling","year":"2022","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2023.01.033_bib125","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib126","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1002\/hep.28123","article-title":"Association of nonalcoholic fatty liver disease (NAFLD) with hepatocellular carcinoma (HCC) in the United States from 2004 to 2009","volume":"62","author":"Younossi","year":"2015","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib127","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cgh.2020.05.064","article-title":"Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States","volume":"19","author":"Younossi","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib130","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/hep4.1510","article-title":"Nonalcoholic fatty liver disease and alcoholic liver disease are major drivers of liver mortality in the United States","volume":"4","author":"Paik","year":"2020","journal-title":"Hepatol Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib131","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1001\/jama.2018.16789","article-title":"Screening and behavioral counseling interventions to reduce unhealthy alcohol use in adolescents and adults: US Preventive Services Task Force Recommendation Statement","volume":"320","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2023.01.033_bib132","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/liv.13502","article-title":"Hepatocellular carcinoma in South America: evaluation of risk factors, demographics and therapy","volume":"38","author":"Debes","year":"2018","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib133","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100876","article-title":"Changing epidemiology of hepatocellular carcinoma in South America: a report from the South American liver research network","volume":"28","author":"Farah","year":"2023","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib134","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib135","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/cld.759","article-title":"Nonalcoholic fatty liver disease risk factors in Latin American populations: current scenario and perspectives","volume":"13","author":"Pinto Marques Souza de Oliveira","year":"2019","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2023.01.033_bib136","doi-asserted-by":"crossref","first-page":"792","DOI":"10.4254\/wjh.v12.i10.792","article-title":"PNPLA3 and TM6SF2 polymorphisms in Brazilian patients with nonalcoholic fatty liver disease","volume":"12","author":"Lisboa","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib137","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib138","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1111\/tri.13358","article-title":"2018 Annual report of the European liver transplant registry (ELTR)\u201350-year evolution of liver transplantation","volume":"31","author":"Adam","year":"2018","journal-title":"Transpl Int"},{"key":"10.1053\/j.gastro.2023.01.033_bib139","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijsu.2020.05.062","article-title":"Current status of liver transplantation in Europe","volume":"82","author":"M\u00fcller","year":"2020","journal-title":"Int J Surg"},{"key":"10.1053\/j.gastro.2023.01.033_bib140","doi-asserted-by":"crossref","first-page":"8162","DOI":"10.3390\/ijerph17218162","article-title":"Alcohol control policy in Europe: overview and exemplary countries","volume":"17","author":"Berdzuli","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1053\/j.gastro.2023.01.033_bib141","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0140-6736(18)32744-2","article-title":"Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study","volume":"393","author":"Manthey","year":"2019","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.01.033_bib142","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.jhep.2019.04.011","article-title":"Outcomes of liver transplantation for non-alcoholic steatohepatitis: a European liver transplant registry study","volume":"71","author":"Haldar","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib143","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib144","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.08.027","article-title":"A\u00a0cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe","volume":"72","author":"Lazarus","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jhep.2016.08.013","article-title":"Time trends of chronic HBV infection over prior decades - a global analysis","volume":"66","author":"Ott","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib146","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(21)01701-3","article-title":"The EASL-Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality","volume":"399","author":"Karlsen","year":"2022","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2023.01.033_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-77515-y","article-title":"Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C in China and the United States","volume":"10","author":"Yang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2023.01.033_bib148","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.21873\/anticanres.11069","article-title":"Ageing as an important risk factor for cancer","volume":"36","author":"Smetana","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1053\/j.gastro.2023.01.033_bib149","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.drudis.2021.02.001","article-title":"Toward improving androgen receptor-targeted therapies in male-dominant hepatocellular carcinoma","volume":"26","author":"Zhang","year":"2021","journal-title":"Drug Discov Today"},{"key":"10.1053\/j.gastro.2023.01.033_bib150","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000315247","article-title":"Gender disparity of hepatocellular carcinoma: the roles of sex hormones","volume":"78","author":"Yeh","year":"2010","journal-title":"Oncology"},{"key":"10.1053\/j.gastro.2023.01.033_bib151","author":"Joann"},{"key":"10.1053\/j.gastro.2023.01.033_bib152","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/GIM.0b013e31819d30f2","article-title":"HFE-associated hereditary hemochromatosis","volume":"11","author":"Alexander","year":"2009","journal-title":"Genet Med"},{"key":"10.1053\/j.gastro.2023.01.033_bib153","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1053\/j.gastro.2003.09.035","article-title":"Cancer risk in patients with hereditary hemochromatosis and in their first-degree relatives","volume":"125","author":"Elmberg","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib154","first-page":"183","article-title":"Hereditary hemochromatosis","volume":"87","author":"Crownover","year":"2013","journal-title":"Am Fam Physician"},{"key":"10.1053\/j.gastro.2023.01.033_bib155","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.14309\/ajg.0000000000000315","article-title":"ACG clinical guideline: hereditary hemochromatosis","volume":"114","author":"Kowdley","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib156","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/s41436-018-0309-9","article-title":"The global prevalence of Wilson disease from next-generation sequencing data","volume":"21","author":"Gao","year":"2019","journal-title":"Genet Med"},{"key":"10.1053\/j.gastro.2023.01.033_bib157","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1136\/gut.2005.087262","article-title":"Clinical presentation, diagnosis and long-term outcome of Wilson\u2019s disease: a cohort study","volume":"56","author":"Merle","year":"2007","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.01.033_bib158","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70976-1","article-title":"A\u00a0population-based epidemiology of Wilson\u2019s disease in South Korea between 2010 and 2016","volume":"10","author":"Choe","year":"2020","journal-title":"Sci Rep"},{"key":"10.1053\/j.gastro.2023.01.033_bib159","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/jgh.12716","article-title":"No increased risk of hepatocellular carcinoma in cirrhosis due to Wilson disease during long-term follow-up","volume":"30","author":"van Meer","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/978-3-319-55780-9_9","article-title":"Liver cancer in tyrosinemia type 1","volume":"959","author":"van Ginkel","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1053\/j.gastro.2023.01.033_bib161","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1399-3046.2005.00395.x","article-title":"Hepatocellular carcinoma in children and effect of living-donor liver transplantation on outcome","volume":"10","author":"Arikan","year":"2006","journal-title":"Pediatr Transpl"},{"key":"10.1053\/j.gastro.2023.01.033_bib162","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1002\/pbc.25094","article-title":"HCC prevalence and histopathological findings in liver explants of patients with hereditary tyrosinemia type 1","volume":"61","author":"Seda Neto","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib163","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2019.01.004","article-title":"Porphyria cutanea tarda: recent update","volume":"128","author":"Singal","year":"2019","journal-title":"Mol Genet Metab"},{"key":"10.1053\/j.gastro.2023.01.033_bib164","author":"Aniruddh Shah"},{"key":"10.1053\/j.gastro.2023.01.033_bib165","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1053\/j.gastro.2019.04.050","article-title":"Clinical guide and update on porphyrias","volume":"157","author":"St\u00f6lzel","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib166","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/cld.896","article-title":"Update on alpha-1 antitrypsin deficiency in liver disease","volume":"15","author":"Narayanan","year":"2020","journal-title":"Clin Liver Dis"},{"key":"10.1053\/j.gastro.2023.01.033_bib167","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00535-019-01548-y","article-title":"Liver disease in adults with severe alpha-1-antitrypsin deficiency","volume":"54","author":"Tanash","year":"2019","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib168","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.144365","article-title":"A\u00a0comprehensive evaluation of single nucleotide polymorphisms associated with hepatocellular carcinoma risk in Asian populations: a systematic review and network meta-analysis","volume":"735","author":"Zhang","year":"2020","journal-title":"Gene"},{"key":"10.1053\/j.gastro.2023.01.033_bib169","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.jhep.2012.02.035","article-title":"Single nucleotide polymorphisms and risk of hepatocellular carcinoma in cirrhosis","volume":"57","author":"Nahon","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib170","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1470-2045(21)00603-3","article-title":"Common genetic variation in alcohol-related hepatocellular carcinoma: a case-control genome-wide association study","volume":"23","author":"Tr\u00e9po","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib171","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/nar\/gkab1049","article-title":"Ensembl 2022","volume":"50","author":"Cunningham","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.gastro.2023.01.033_bib172","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1038\/ng.3417","article-title":"A\u00a0genome-wide association study confirms PNPLA3 and identifies TM6SF2 and MBOAT7 as risk loci for alcohol-related cirrhosis","volume":"47","author":"Buch","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2023.01.033_bib173","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1080\/17474124.2022.2032661","article-title":"Research progress on the relationship between TM6SF2 rs58542926 polymorphism and non-alcoholic fatty liver disease","volume":"16","author":"Xue","year":"2022","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib174","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1186\/s12885-019-6173-4","article-title":"Association of TM6SF2 rs58542926 T\/C gene polymorphism with hepatocellular carcinoma: a meta-analysis","volume":"19","author":"Tang","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib175","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1038\/ncomms5309","article-title":"TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease","volume":"5","author":"Liu","year":"2014","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib176","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ajg.2013.476","article-title":"The effect of PNPLA3 on fibrosis progression and development of hepatocellular carcinoma: a meta-analysis","volume":"109","author":"Singal","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2023.01.033_bib177","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jhep.2020.11.024","article-title":"Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores","volume":"74","author":"Bianco","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib178","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.jhep.2021.02.030","article-title":"Reply to: Polygenic risk score: a promising predictor for hepatocellular carcinoma in the population with non-alcoholic fatty liver disease","volume":"74","author":"Jamialahmadi","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib179","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1940-6207.CAPR-21-0189","article-title":"Germline cancer susceptibility gene testing in unselected patients with hepatobiliary cancers: a multi-center prospective study","volume":"15","author":"Uson","year":"2022","journal-title":"Cancer Prev Res"},{"key":"10.1053\/j.gastro.2023.01.033_bib180","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1200\/PO.21.00079","article-title":"Multigene panel testing in individuals with hepatocellular carcinoma identifies pathogenic germline variants","volume":"5","author":"Mezina","year":"2021","journal-title":"JCO Precis Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib181","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s00280-015-2852-2","article-title":"Phase II study of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma","volume":"76","author":"Gabrielson","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1053\/j.gastro.2023.01.033_bib182","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1158\/0008-5472.CAN-18-1273","article-title":"EGFR and c-MET cooperate to enhance resistance to PARP inhibitors in hepatocellular carcinoma","volume":"79","author":"Dong","year":"2019","journal-title":"Cancer Res"},{"key":"10.1053\/j.gastro.2023.01.033_bib183","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1002\/cam4.1998","article-title":"Real impact of liver cirrhosis on the development of hepatocellular carcinoma in various liver diseases-meta-analytic assessment","volume":"8","author":"Tarao","year":"2019","journal-title":"Cancer Med"},{"key":"10.1053\/j.gastro.2023.01.033_bib184","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1634\/theoncologist.2010-S4-14","article-title":"The etiology of hepatocellular carcinoma and consequences for treatment","volume":"15","author":"Sanyal","year":"2010","journal-title":"Oncologist"},{"key":"10.1053\/j.gastro.2023.01.033_bib185","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"key":"10.1053\/j.gastro.2023.01.033_bib186","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/hep.31394","article-title":"Genetics of hepatocellular carcinoma: approaches to explore molecular diversity","volume":"73","author":"Caruso","year":"2021","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib187","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ng.3252","article-title":"Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets","volume":"47","author":"Schulze","year":"2015","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2023.01.033_bib188","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.jhep.2016.05.035","article-title":"Genetic profiling of hepatocellular carcinoma using next-generation sequencing","volume":"65","author":"Schulze","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib189","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1038\/s41467-020-18186-1","article-title":"The genomic landscape of Mongolian hepatocellular carcinoma","volume":"11","author":"Candia","year":"2020","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib190","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s41467-019-14050-z","article-title":"Intratumoral heterogeneity and clonal evolution in liver cancer","volume":"11","author":"Losic","year":"2020","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib191","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40164-022-00277-y","article-title":"Heterogeneity of the tumor immune microenvironment and its clinical relevance","volume":"11","author":"Jia","year":"2022","journal-title":"Exp Hematol Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib192","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s41467-020-20171-7","article-title":"Intratumoural immune heterogeneity as a hallmark of tumour evolution and progression in hepatocellular carcinoma","volume":"12","author":"Nguyen","year":"2021","journal-title":"Nat Commun"},{"issue":"3","key":"10.1053\/j.gastro.2023.01.033_bib193","doi-asserted-by":"crossref","first-page":"nwab192","DOI":"10.1093\/nsr\/nwab192","article-title":"Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study","volume":"9","author":"Zhai","year":"2021","journal-title":"Natl Sci Rev"},{"key":"10.1053\/j.gastro.2023.01.033_bib194","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41592-021-01203-6","article-title":"Spatial omics and multiplexed imaging to explore cancer biology","volume":"18","author":"Lewis","year":"2021","journal-title":"Nat Methods"},{"key":"10.1053\/j.gastro.2023.01.033_bib195","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2023.01.033_bib196","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2018.07.010","article-title":"Deep profiling of mouse splenic architecture with CODEX multiplexed imaging","volume":"174","author":"Goltsev","year":"2018","journal-title":"Cell"},{"key":"10.1053\/j.gastro.2023.01.033_bib197","first-page":"657","article-title":"627 ImmunoAtlas: an online public portal for sharing, visualizing, and referencing multiplex immunohistochemistry\/immunofluorescence (mIHC\/IF) images and results for immuno-oncology","volume":"9","author":"Joey Lee","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib198","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nmeth1032","article-title":"Image-based multivariate profiling of drug responses from single cells","volume":"4","author":"Loo","year":"2007","journal-title":"Nat Methods"},{"key":"10.1053\/j.gastro.2023.01.033_bib199","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/cyto.a.22909","article-title":"Large-scale image-based screening and profiling of cellular phenotypes","volume":"91","author":"Bougen-Zhukov","year":"2017","journal-title":"Cytometry A"},{"issue":"Suppl16","key":"10.1053\/j.gastro.2023.01.033_bib200","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/1471-2105-14-S16-S4","article-title":"CellXpress: a fast and user-friendly software platform for profiling cellular phenotypes","volume":"14","author":"Laksameethanasan","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"10.1053\/j.gastro.2023.01.033_bib201","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ccell.2022.07.004","article-title":"Pan-cancer integrative histology-genomic analysis via multimodal deep learning","volume":"40","author":"Chen","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1053\/j.gastro.2023.01.033_bib202","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113959","article-title":"Leveraging advances in immunopathology and artificial intelligence to analyze in\u00a0vitro tumor models in composition and space","volume":"177","author":"Leong","year":"2021","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1053\/j.gastro.2023.01.033_bib203","doi-asserted-by":"crossref","first-page":"5524","DOI":"10.3390\/cancers13215524","article-title":"Intratumor heterogeneity in hepatocellular carcinoma: challenges and opportunities","volume":"13","author":"Kalasekar","year":"2021","journal-title":"Cancers"},{"key":"10.1053\/j.gastro.2023.01.033_bib204","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1136\/gutjnl-2019-320282","article-title":"Liquid biopsy in the clinical management of hepatocellular carcinoma","volume":"69","author":"von Felden","year":"2020","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2023.01.033_bib205","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1038\/s41416-021-01467-x","article-title":"The gut microbiome: what the oncologist ought to know","volume":"125","author":"Lee","year":"2021","journal-title":"Br J Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib206","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.transproceed.2016.01.077","article-title":"Profile of gut microbiota associated with the presence of hepatocellular cancer in patients with liver cirrhosis","volume":"48","author":"Gr\u0105t","year":"2016","journal-title":"Transplant Proc"},{"key":"10.1053\/j.gastro.2023.01.033_bib207","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3389\/fmicb.2019.01458","article-title":"Analysis of the relationship between the degree of dysbiosis in gut microbiota and prognosis at different stages of primary hepatocellular carcinoma","volume":"10","author":"Ni","year":"2019","journal-title":"Front Microbiol"},{"key":"10.1053\/j.gastro.2023.01.033_bib208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/hep.30036","article-title":"Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease","volume":"69","author":"Ponziani","year":"2019","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2023.01.033_bib209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat Commun"},{"key":"10.1053\/j.gastro.2023.01.033_bib210","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC\u2013mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib211","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/nature12347","article-title":"Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome","volume":"499","author":"Yoshimoto","year":"2013","journal-title":"Nature"},{"key":"10.1053\/j.gastro.2023.01.033_bib212","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1158\/2159-8290.CD-16-0932","article-title":"Gut microbiota promotes obesity-associated liver cancer through PGE2-mediated suppression of antitumor immunity","volume":"7","author":"Loo","year":"2017","journal-title":"Cancer Discov"},{"key":"10.1053\/j.gastro.2023.01.033_bib213","doi-asserted-by":"crossref","first-page":"9925","DOI":"10.18632\/oncotarget.24066","article-title":"Bile acid metabolism regulated by the gut microbiota promotes non-alcoholic steatohepatitis-associated hepatocellular carcinoma in mice","volume":"9","author":"Yamada","year":"2018","journal-title":"Oncotarget"},{"key":"10.1053\/j.gastro.2023.01.033_bib214","doi-asserted-by":"crossref","first-page":"7800","DOI":"10.3390\/ijms22157800","article-title":"Hepatocellular carcinoma immunotherapy and the potential influence of gut microbiome","volume":"22","author":"Temraz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.gastro.2023.01.033_bib215","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4251\/wjgo.v14.i5.947","article-title":"Gut microbiome in non-alcoholic fatty liver disease associated hepatocellular carcinoma: current knowledge and potential for therapeutics","volume":"14","author":"Said","year":"2022","journal-title":"World J Gastrointest Oncol"},{"key":"10.1053\/j.gastro.2023.01.033_bib216","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.3390\/ijms20246267","article-title":"The microbiota and cancer cachexia","volume":"20","author":"Herremans","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1053\/j.gastro.2023.01.033_bib217","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nrgastro.2017.20","article-title":"Gut microbiota modulation of chemotherapy efficacy and toxicity","volume":"14","author":"Alexander","year":"2017","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib218","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1186\/s12885-021-08904-3","article-title":"Survival improvement and prognosis for hepatocellular carcinoma: analysis of the SEER database","volume":"21","author":"Ding","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2023.01.033_bib219","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","volume":"77","author":"Singal","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib220","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib221","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1053\/j.gastro.2019.02.049","article-title":"Surveillance for hepatocellular carcinoma: current best practice and future direction","volume":"157","author":"Kanwal","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2023.01.033_bib222","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","author":"Galle","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2023.01.033_bib223","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508523001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508523001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:41:09Z","timestamp":1758037269000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508523001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":213,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0016508523001051"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global Epidemiology and Genetics of Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2023.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute.","name":"copyright","label":"Copyright"}]}}